cytidine diphosphate choline has been researched along with Inflammatory Bowel Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Gao, Y; Guo, L; Jiang, H; Xu, M; Zhang, F; Zhou, F | 1 |
| Appleyard, CB; Hillier, K | 1 |
2 other study(ies) available for cytidine diphosphate choline and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
CDP-choline modulates cholinergic signaling and gut microbiota to alleviate DSS-induced inflammatory bowel disease.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Choline; Colitis; Colon; Cytidine Diphosphate Choline; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Humans; Inflammation; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; Nicotinic Antagonists | 2023 |
Biosynthesis of platelet-activating factor in normal and inflamed human colon mucosa: evidence for the involvement of the pathway of platelet-activating factor synthesis de novo in inflammatory bowel disease.
Topics: Aged; Azepines; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Colon; Culture Techniques; Cytidine Diphosphate Choline; Female; Glyceryl Ethers; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Middle Aged; Platelet Activating Factor; Triazoles | 1995 |